Nonetheless, our results demonstrate that inhibiting S100A9 in tumor cells either by genetic means or using an S100A9 inhibitor significantly impedes the recruitment of immunosuppressive granulocytic MDSCs in the tumor. Here, S100A9 is linked to neoplasm.